Data / Drug companies / Hikal Limited
Hikal Limited: 35 products in the FDA NDC directory, labeler code 66651
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hikal Limited (labeler code 66651) lists 35 products in the FDA National Drug Code Directory. By type: 35 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 20, 2026.
The request: Watch Hikal Limited (FDA labeler code 66651): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66651
- Products in commercial distribution
- 35
- Packages
- 247
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1, Schedule V 2
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- January 12, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 35 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cariprazine hydrochloride | 66651-935 | Powder | Bulk ingredients | May 20, 2026 |
| Vonoprazan fumarate | 66651-934 | Powder | Bulk ingredients | May 20, 2026 |
| Bupropion hydrochloride | 66651-501 | Powder | Bulk ingredients | May 12, 2026 |
| Lubabegron fumarate | 66651-933 | Powder | Bulk ingredients | March 28, 2025 |
| Edoxaban tosylate monohydrate | 66651-932 | Powder | Bulk ingredients | October 1, 2024 |
| Celecoxib | 66651-502 | Powder | Bulk ingredients | September 12, 2023 |
| Rivaroxaban | 66651-503 | Powder | Bulk ingredients | August 18, 2023 |
| Bupropion hydrobromide | 66651-930 | Powder | Bulk ingredients | June 16, 2023 |
| Bupropion hydrobromide | 66651-929 | Powder | Bulk ingredients | April 10, 2023 |
| Desvenlafaxine succinate | 66651-928 | Powder | Bulk ingredients | August 19, 2022 |
| Vildagliptin | 66651-102 | Powder | Bulk ingredients | December 1, 2021 |
| Sitagliptin phosphate anhydrate | 66651-925 | Powder | Bulk ingredients | October 19, 2020 |
| Ertugliflozin | 66651-926 | Powder | Bulk ingredients | December 20, 2019 |
| Dapagliflozin propanediol | 66651-924 | Powder | Bulk ingredients | December 20, 2019 |
| Sitagliptin hydrochloride | 66651-923 | Powder | Bulk ingredients | September 11, 2019 |
| Pyrimethamine | 66651-922 | Powder | Bulk ingredients | December 15, 2017 |
| Apixaban | 66651-921 | Powder | Bulk ingredients | December 12, 2017 |
| Butorphanol tartrate | 66651-920 | Powder | Bulk ingredients | July 24, 2017 |
| Celecoxib | 66651-919 | Powder | Bulk ingredients | July 24, 2017 |
| Dabigatran etexilate mesylate | 66651-918 | Powder | Bulk ingredients | July 24, 2017 |
| Sitagliptin phosphate | 66651-917 | Powder | Bulk ingredients | July 24, 2017 |
| Valacyclovir hydrochloride | 66651-916 | Powder | Bulk ingredients | July 24, 2017 |
| Pregabalin | 66651-915 | Powder | Bulk ingredients | July 24, 2017 |
| Lacosamide | 66651-914 | Powder | Bulk ingredients | July 24, 2017 |
| Pentoxifylline | 66651-912 | Powder | Bulk ingredients | August 18, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.